Company DescriptionNootropics describe a broad classification compounds with cognitive enhancing properties with minimal side-effects and appropriate for long-term use. We understand that human understanding and research behind nootropics, cognitive modulation, and broader biohacking is constantly evolving and improving.

Proceeds PurposesThe new capital will allow us to accelerate clinical research and development on nootropics, to double down on our manufacturing and supply chain innovation, and to continue building a world class team across all disciplines of medicine, software, and product manufacturing.